By inhibiting the NNMT enzyme, it prevents the excessive consumption of NAD+, a critical molecule that your cells need for energy production, DNA repair, and maintaining healthy metabolic function
Mar 2018;28(2):339-351
In early phase 2a trials, it effectively improved glycemic control, increased post-meal insulin levels, and facilitated weight loss in participants with obesity and patients with T2DM [83]
(visit source) Desneves KJ, Todorovic BE, Cassar A, Crowe TC
Pre-measured strips
Participants who received semaglutide had greater reductions in the number of heavy drinking days (41% fewer, on average) compared to those receiving placebo (26%.) The amount of alcohol consumed over the prior 30 days dropped by over 70% in the semaglutide group (from 78 ounces of 100% alcohol at baselinethe equivalent of 130 shots of 80-proof spirits over 30 daysto 23 ounces, or about 39 shots)